RecruitingNCT05024175

Long-term Follow-up of Subjects Treated With CAR T Cells

Sponsor

Marcela V. Maus, M.D.,Ph.D.

Enrollment

45 participants

Start Date

Aug 7, 2023

Study Type

OBSERVATIONAL

Conditions

Adult Progression Free Survival Overall Survival Disease Free Survival CAR-T Long Term Adverse Effects Duty to Follow Up

Summary

This is a single site, non-randomized, open-label, long-term safety and efficacy follow-up study for Phase 1 studies that evaluate the safety and efficacy of CAR T cells: NCT05660369 (DF/HCC# 22-175) and NCT06026319 (DF/HCC# 23-474).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood test, Disease assessments, and others for people with adult, car-t, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.